Shenzhen Lifotronic Technology Co., Ltd.
SHH: 688389.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Ming Long Hu
- Employees
- 1,670
- Headquarters
- Shenzhen, China
- IPO year
- 2019
- Market cap
- CN¥5.6B
- Website
- https://www.lifotronic.com
Loading 688389…
Loading profile data…Frequently asked questions about 688389
What does Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) do?
Shenzhen Lifotronic Technology Co., Ltd. develops, manufactures, and markets medical devices for diagnostic and therapeutic purposes in China. The company offers IVD products, such as HPLC systems, including hemoglobin and HbA1c analyzers, ECLIA systems comprising automated ECL immunoassay analyzers; hematology analyzers; POCT, such as immunoflu...
Where does 688389.SS trade?
Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) trades on the Shanghai Stock Exchange.
What sector is 688389.SS in?
Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Shenzhen Lifotronic Technology Co., Ltd.?
Ming Long Hu is the chief executive officer of Shenzhen Lifotronic Technology Co., Ltd. (688389.SS).
Where is Shenzhen Lifotronic Technology Co., Ltd. headquartered?
Shenzhen Lifotronic Technology Co., Ltd. is headquartered in China.
Does 688389.SS pay a dividend?
Yes — Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) paid a trailing twelve-month dividend of CNY 0.28 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688389.SS go public?
Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) completed its initial public offering in 2019.